CDRD - Novel Strategies in Cancer Immunotherapy Symposium
May 26 @ 8:30 AM - 2:00 PM
CDRD, Canada's national drug development and commercialization engine, is hosting a symposium “Novel strategies in cancer immunotherapy.”
Join us and top cancer researchers and clinicians from across Canada to learn about novel platforms in cancer immunotherapy research, implications for the discovery of therapeutic candidates, lessons learned, and to discuss how novel platforms may advance cancer immunotherapy R&D in Canada.
This event features a keynote address by Dr. Jason Berman, IWK Health Centre, additional concise talks, a moderated panel discussion and opportunities to network and explore potential partnerships and collaborations.
drug, development, commercialization, research, university
The Centre for Drug Research and Development (CDRD) is Canada's fully-integrated national drug development and commercialization centre, providing expertise and infrastructure to enable researchers from leading health research institutions to advance promising early-stage drug candidates. Our mandate is to de-risk discoveries stemming from publicly-funded health research and transform them into viable investment opportunities for the private sector — thus successfully bridging the commercialization gap between academia and industry, and translating research discoveries into new therapies for patients. Canada's Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).
The Centre for Drug Research and Development (CDRD) addresses one of the biggest challenges facing the life sciences sector today: how to translate commercially promising health research conducted at the university level into new therapies that improve and save lives.
Canada invests billions of dollars in medical research each year and our universities have achieved impressive results in terms of scientific discoveries. Yet it is extremely difficult to translate these discoveries into commercial products. The main reason is risk.
That's where CDRD comes in.
CDRD is Canada's national, not-for-profit drug development and commercialization centre. Our mandateis to de-risk discoveries stemming from publicly funded research to create viable investment opportunities for the private sector — thereby bridging the commercialization gap between early-stage academic research and industry. CDRD is the only fully-integrated centre of its kind in the country — and one of a handful in the world — with the full expertise and infrastructure to source, evaluate, develop and commercialize both small molecule and biologic innovative technologies in virtually any therapeutic area.
CDRD was born of a shared vision between government, industry and academia. We were founded in 2007 as an independent, not-for-profit organization by a group of renowned academic investigators and business people with proven track records in creating new medicines. Just one year later, we were recognized by the Government of Canada as a national Centre of Excellence in Commercialization and Research (CECR).
We provide one-stop, structured access to multiple research institutions, and produces a continuous pipeline of pre-validated and de-risked technologies that can be efficiently and cost-effectively brought to market. Our single mandate of commercialization results in cost-efficient collaboration and development using CDRD's existing networks, facilities, and infrastructure.
Our commercial arm, CDRD Ventures Inc. (CVI), acts as the interface between CDRD and industry to drive drug development and technology commercialization further. CVI in-licenses selected intellectual property generated from CDRD projects directly from the affiliated institution or inventor, and forms strategic partnerships with pharmaceutical and biotechnology companies to transform promising drug research into much-needed medical therapeutics. Profits from CVI flow back to CDRD to support future drug development projects.
Third Floor - 2259 Lower Mall Vancouver, BC V6T 1Z4 Canada [ MAP ]